LMRNX
Price
$35.20
Change
+$0.02 (+0.06%)
Updated
Jul 10 closing price
Net Assets
908.83M
VBAIX
Price
$54.47
Change
+$0.09 (+0.17%)
Updated
Jul 10 closing price
Net Assets
63.7B
Interact to see
Advertisement

LMRNX vs VBAIX

LMRNX vs VBAIX Comparison Chart in %
View a ticker or compare two or three
VS
LMRNX vs. VBAIX commentary
Jul 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMRNX is a Buy and VBAIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VBAIX has more cash in the bank: 63.7B vs. LMRNX (909M). VBAIX pays higher dividends than LMRNX: VBAIX (2.07) vs LMRNX (0.99). LMRNX was incepted earlier than VBAIX: LMRNX (18 years) vs VBAIX (26 years). LMRNX (0.69) is less costly to investors than VBAIX (0.04). VBAIX is a more actively managed with annual turnover of: 31.00 vs. LMRNX (11.00). LMRNX has a lower initial minimum investment than VBAIX: LMRNX (1000000) vs VBAIX (5000000). VBAIX annual gain was more profitable for investors over the last year : 9.96 vs. LMRNX (8.43). LMRNX return over 5 years is better than : 34.54 vs. VBAIX (20.39).
LMRNXVBAIXLMRNX / VBAIX
Total Expense Ratio0.690.041,725%
Annual Report Gross Expense Ratio0.690.041,725%
Fund Existence18 years26 years-
Gain YTD3.4635.79160%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets909M63.7B1%
Annual Yield % from dividends0.992.0748%
Returns for 1 year8.439.9685%
Returns for 3 years42.6431.59135%
Returns for 5 years34.5420.39169%
Returns for 10 years116.7497.30120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DISAX22.68N/A
N/A
BNY Mellon International Stock Fund A
WFSTX11.15N/A
N/A
Allspring Innovation Fund - Class A
AFOYX19.36N/A
N/A
Ariel Focus Institutional
HFDCX20.43N/A
N/A
Hartford Schroders US MidCap Opps C
JGTTX40.26N/A
N/A
JPMorgan Growth Advantage R3